Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sutro Biopharma Inc
(NQ:
STRO
)
3.770
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
3.770
Bid (Size)
3.710 (8)
Ask (Size)
4.320 (5)
Prev. Close
3.770
Today's Range
3.770 - 3.770
52wk Range
2.005 - 5.880
Shares Outstanding
60,416,916
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What's Going On With Sutro Biopharma (STRO) Stock?
April 02, 2024
Sutro Biopharma shares are trading lower by 4.3% during Tuesday's session. The company announced the pricing of an underwritten offering.
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 28, 2024
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...
Via
Benzinga
Performance
YTD
-17.51%
-17.51%
1 Month
+15.29%
+15.29%
3 Month
-15.47%
-15.47%
6 Month
+27.80%
+27.80%
1 Year
-18.04%
-18.04%
More News
Read More
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
Via
Benzinga
Navigating 4 Analyst Ratings For Sutro Biopharma
March 27, 2024
Via
Benzinga
Expert Ratings for Sutro Biopharma
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 26, 2024
Via
Benzinga
STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q4 2023
March 25, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 30, 2023
Via
Benzinga
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
November 27, 2023
From
Vaxcyte, Inc.
Via
GlobeNewswire
Where Sutro Biopharma Stands With Analysts
October 23, 2023
Via
Benzinga
5 Analysts Have This to Say About Sutro Biopharma
October 06, 2023
Via
Benzinga
Where Sutro Biopharma Stands With Analysts
August 11, 2023
Via
Benzinga
6 Analysts Have This to Say About Sutro Biopharma
June 12, 2023
Via
Benzinga
Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside
October 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
April 03, 2023
Via
Benzinga
Where Sutro Biopharma Stands With Analysts
March 31, 2023
Via
Benzinga
Sutro Biopharma Posts Updated Data From Ovarian Cancer Candidate
January 10, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
Via
Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 18, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
Via
Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
January 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 09, 2023
Via
Benzinga
Why Investors Are Suddenly Excited About Vaxcyte
October 31, 2022
Via
MarketBeat
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.